Theoretically, by selectively knocking down p53 expression during cancer treatment in specific tumors, you may sensitize the tumor to chemotherapy while protecting the CFs, and thereby the heart, from disrupted mitophagy. The gene discussed is TP53; the disease is neoplasm.